marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-13-2024
KemPharm Balance Sheet 2011-2024 | KMPH
Annual Balance Sheet KemPharm
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-42 M | -64.1 M | -111 M | 64.2 M | 76.3 M | 63 M | 81.9 M | 125 M | -9.24 M | 7.89 M | 2 M | - | - |
Long Term Debt |
456 K | 843 K | 1.23 M | 68 M | 77.3 M | 78.1 M | 89.4 M | 91.2 M | 19.7 M | 18.1 M | 34.8 K | - | - |
Long Term Debt Current |
543 K | 480 K | 356 K | 327 K | 284 K | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | 79.5 M | 81.3 M | 98.5 M | 96.9 M | 57.5 M | 34.1 M | 21.5 M | - | - |
Total Current Liabilities |
73.7 M | 12 M | 4.23 M | 7.54 M | 5.43 M | 12 M | 11.5 M | 6.64 M | 8.34 M | - | - | - | - |
Total Liabilities |
110 M | 40.2 M | 5.82 M | 77.6 M | 85 M | 93.3 M | 110 M | 104 M | 65.8 M | 38 M | 26.7 M | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-400 M | -354 M | -267 M | -258 M | -246 M | -221 M | -165 M | -121 M | -105 M | -50.2 M | -25.7 M | - | - |
Total Assets |
172 M | 115 M | 133 M | 11.2 M | 10.5 M | 26.7 M | 52.5 M | 84.9 M | 55.7 M | 13.7 M | 2.43 M | - | - |
Cash and Cash Equivalents |
43 M | 65.5 M | 112 M | 4.21 M | 3.22 M | 18.4 M | 10.9 M | 16.8 M | 32.3 M | 10.3 M | 1.97 M | - | - |
Book Value |
61.9 M | 75.1 M | 127 M | -66.4 M | -74.5 M | -66.6 M | -57.5 M | -18.7 M | -10.1 M | -24.3 M | -24.3 M | - | - |
Total Shareholders Equity |
61.9 M | 75.1 M | 102 M | -66.4 M | -74.5 M | -66.6 M | -57.5 M | -18.7 M | -10.1 M | -48.5 M | -24.3 M | - | - |
All numbers in USD currency
Quarterly Balance Sheet KemPharm
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
58.9 M | - | - | 5.07 M | 517 K | 627 K | 736 K | 843 K | - | 1.08 M | 1.14 M | 1.23 M | 1.32 M | 1.41 M | 1.5 M | 67.7 M | 781 K | 781 K | 68.6 M | 77.3 M | 77.3 M | 77.3 M | 77.3 M | 81.4 M | - | - | - | 92.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
122 M | - | 102 M | 110 M | 71.5 M | 37 M | 35.2 M | 29.7 M | - | 25 M | 4.21 M | 5.82 M | 5.45 M | 8.13 M | 6.18 M | 77.6 M | 77.6 M | 77.6 M | 77.6 M | 85 M | 85 M | 85 M | 85 M | 93.3 M | 93.3 M | 93.3 M | 93.3 M | 110 M | 110 M | 110 M | 110 M | 104 M | 104 M | 104 M | 104 M | 64.7 M | 64.7 M | 64.7 M | 64.7 M | 38 M | 38 M | 38 M | 38 M | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-470 M | - | -416 M | -400 M | -339 M | -325 M | -320 M | -309 M | - | -293 M | -269 M | -267 M | -264 M | -263 M | -269 M | -258 M | -258 M | -258 M | -258 M | -246 M | -246 M | -246 M | -246 M | -221 M | -221 M | -221 M | -221 M | -165 M | -165 M | -165 M | -165 M | -121 M | -121 M | -121 M | -121 M | -105 M | -105 M | -105 M | -105 M | -50.2 M | -50.2 M | -50.2 M | -50.2 M | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
192 M | - | 151 M | 172 M | 139 M | 106 M | 107 M | 116 M | - | 124 M | 126 M | 133 M | 137 M | 139 M | 90.4 M | 11.2 M | 11.2 M | 11.2 M | 11.2 M | 10.5 M | 10.5 M | 10.5 M | 10.5 M | 26.7 M | 26.7 M | 26.7 M | 26.7 M | 52.5 M | 52.5 M | 52.5 M | 52.5 M | 84.9 M | 84.9 M | 84.9 M | 84.9 M | 54.6 M | 54.6 M | 54.6 M | 54.6 M | 13.7 M | 13.7 M | 13.7 M | 13.7 M | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
54 M | - | 42.8 M | 43 M | 43.3 M | 66.2 M | 40.2 M | 65.5 M | - | 76.8 M | 100 M | 112 M | 132 M | 132 M | 75.9 M | 4.21 M | 4.21 M | 4.21 M | 4.21 M | 3.22 M | 3.22 M | 3.22 M | 3.22 M | 18.4 M | 18.4 M | 18.4 M | 18.4 M | 10.9 M | 10.9 M | 10.9 M | 10.9 M | 16.8 M | 16.8 M | 16.8 M | 16.8 M | 32.3 M | 32.3 M | 32.3 M | 32.3 M | 10.3 M | 10.3 M | 10.3 M | 10.3 M | 1.97 M | - | - | - | 2.54 M | - | - | - | - | - | - | - |
Book Value |
69.8 M | - | 48.8 M | 61.9 M | 67.5 M | 68.5 M | 71.4 M | 85.8 M | - | 99.2 M | 121 M | 127 M | 132 M | 131 M | 84.3 M | -66.4 M | -66.4 M | -66.4 M | -66.4 M | -74.5 M | -74.5 M | -74.5 M | -74.5 M | -66.6 M | -66.6 M | -66.6 M | -66.6 M | -57.5 M | -57.5 M | -57.5 M | -57.5 M | -18.7 M | -18.7 M | -18.7 M | -18.7 M | -10.1 M | -10.1 M | -10.1 M | -10.1 M | -24.3 M | -24.3 M | -24.3 M | -24.3 M | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
69.8 M | 32.5 M | 48.8 M | 61.9 M | 61.5 M | 68.5 M | 59.3 M | 85.8 M | 93.8 M | 99.2 M | 121 M | 127 M | 132 M | 131 M | 84.3 M | -66.4 M | -66.4 M | -66.4 M | -66.4 M | -74.5 M | -74.5 M | -74.5 M | -74.5 M | -66.6 M | -66.6 M | -66.6 M | -66.6 M | -57.5 M | -57.5 M | -57.5 M | -57.5 M | -18.7 M | -18.7 M | -18.7 M | -18.7 M | -10.1 M | -10.1 M | -10.1 M | -10.1 M | -48.5 M | -48.5 M | -48.5 M | -48.5 M | -24.3 M | - | - | - | -19.2 M | - | - | - | - | - | - | - |
All numbers in USD currency